Showing papers by "Christos Dervenis published in 1999"
TL;DR: In this article, the authors present the consensus obtained at a meeting convened to consider the evidence in these areas and provide outcome statements to guide clinical practice, with an assessment of the supporting evidence for each statement.
Abstract: Background
The diagnosis, early assessment, and management of severe acute pancreatitis remain difficult clinical problems This article presents the consensus obtained at a meeting convened to consider the evidence in these areas The aim of the article is to provide outcome statements to guide clinical practice, with an assessment of the supporting evidence for each statement
402 citations
TL;DR: The development of a disease specific questionnaire module to supplement the EORTC core cancer module, the QLQ-C30 in patients with pancreatic cancer, using EOR TC quality of life study group guidelines for module development is reported on.
224 citations
TL;DR: The incorporation of additional chemotherapy with FU and LV into postoperative concomitant RT and bolus infusion of FU does not offer a > or = 10% three-year survival benefit over that of concomant RT andbolus infusionof FU, and significantly increases toxicity in patients with stages II or III rectal cancer.
41 citations
TL;DR: Cure or long-term palliation of pancreatic cancer is generally possible only after complete erradication of the primary tumor, including its local and regional extensions.
Abstract: SummaryCarcinoma of the pancreas is characterized by the high frequency of intrapancreatic (from 75 to 100%) and extrapancreatic neural invasion (from 64 to 69%). Even small-sized tumors
30 citations